Phenomenex (Torrance, California, USA) and the Tecan Group (Männedorf, Switzerland) have announced a new collaboration to co-market automated solid-phase extraction (SPE) products. James O’Brien, Head of Clinical Diagnostics for Tecan, said: “Phenomenex has a large customer base using their SPE products. By co-marketing our robotic workstations with their chemistries, we expect to expand our reach in these high-volume industries.”

www.phenomenex.com